China Universal Asset Management »

Rhythm Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $501k 12k 43.34
2023-12-31 $314k 6.8k 45.93
2023-09-30 $33k 1.5k 22.63
2023-06-30 $12k 745 16.11
2023-03-31 $14k 763 18.35
2022-12-31 $17k 572 29.72
2022-09-30 $12k 475 25.26

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
BlackRock
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
Federated Investors
Perceptive Advisors
Commodore Capital
Checkpoint Capital
Henderson Group
Opaleye Management
T. Rowe Price Associates

View all funds holding Rhythm Pharmaceuticals